New Horizon Health Limited (HK:6606) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
New Horizon Health Limited has announced significant changes to its leadership team, including the resignation of Prof. Hong Wu as an independent non-executive Director due to personal health reasons, and the appointment of Ms. Jiangnan Kong in multiple roles, effective from October 1, 2024. Ms. Kong, with a strong legal and business background, steps in as an independent non-executive Director and takes charge of the Remuneration and Nomination Committees. The company has also highlighted the continued suspension of trading.
For further insights into HK:6606 stock, check out TipRanks’ Stock Analysis page.